DELCATH SYSTEMS, INC.(DCTH)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

DELCATH SYSTEMS, INC. (DCTH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DCTH at 54.7/100 on a 32-signal composite quality model, placing it at rank #1,308 of 2,962 stocks — the top half of the AI-ranked universe. DCTH scores in the top quartile across earnings quality (97.4), revenue growth (94.1). Areas of concern include revenue scale (15.0) and profitability (30.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 6.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), DELCATH SYSTEMS, INC. reports quarterly revenue of $29.1M, net income of $2.7M, free cash flow of $5.2M. Top institutional holders of DCTH by reported 13-F value include Rosalind Advisors, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. DCTH trades on the Nasdaq exchange and files with the SEC under CIK 872912. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DCTH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DELCATH SYSTEMS, INC. directly from SEC EDGAR.

AI Quality Score

54.7/100

AI Rank

#1,308

Revenue

$29.1M

Net Income

$2.7M

Free Cash Flow

$5.2M

DCTH key financials by period

DELCATH SYSTEMS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$85.2M$2.7M0.8%
FY 202410-K$37.2M$-26.4M-33.4%
FY 202310-K$2.1M$-47.7M
FY 202210-K$2.7M$-36.5M
FY 202110-K$3.6M$-25.6M
FY 201710-K$2.7M$-45.1M

Institutions holding DCTH

Institutional investors reporting a position in DELCATH SYSTEMS, INC. on SEC Form 13F.
InstitutionSharesValueReported
Rosalind Advisors3,300,389$41.6M2026-06-30
BlackRock2,706,802$34.1M2026-06-30
VANGUARD CAPITAL MANAGEMENT1,221,247$15.4M2026-06-30
Propel Bio Management871,460$11.0M2026-06-30
GEODE CAPITAL MANAGEMENT733,115$9.2M2026-06-30
STATE STREET679,280$8.6M2026-06-30
ALGERT GLOBAL580,708$7.3M2026-06-30
MILLENNIUM MANAGEMENT566,371$7.1M2026-06-30
Divisadero Street Capital Management499,796$6.3M2026-06-30
MORGAN STANLEY407,983$5.1M2026-06-30
DCTH

DELCATH SYSTEMS, INC.

DCTH
NasdaqSmall CapHealthcare

13F Pro Quality Score

54.7/100

Rank #1,308 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

94.1/100

Profitability

30.5/100

Balance Sheet

36.7/100

Earnings Quality

97.4/100

Free Cash Flow

70.7/100

Institutional Flow

57.6/100

Revenue Scale

15.0/100

Dilution Risk

6.5/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$29.13M

Net Income

Q2 2026
EDGAR

$2.67M

EPS (Diluted)

Q2 2026
EDGAR

$0.07

ROIC

Q2 2026
EDGAR

7.9%

Free Cash Flow

Q2 2026
EDGAR

$5.21M

Top Institutional Holders

as of Q2 2026
$225.44M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…